Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib, Dexamethasone, and High-dose Melphalan for Relapsed Multiple Myeloma
NCT00508209Phase 2Unknown
- Sponsor
- Nordic Myeloma Study Group
- Start
- Jul 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 3
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Nordic Myeloma Study Group. Status: unknown.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00508209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508209.